Showing results (1631-1640 of 1,655) with videos related to

Sort By:
Pageof 166
Nature Communications|January 12, 2024
Epigenetic reprogramming shapes the cellular landscape of schwannomaS John Liu, Tim Casey-Clyde, Nam Woo Cho, et al.
JAMA|January 18, 2022
Effect of P2Y12 Inhibitors on Survival Free of Organ Support Among Non-Critically Ill Hospitalized Patients With COVID-19: A Randomized Clinical TrialJeffrey S Berger, Lucy Z Kornblith, Michelle N Gong, et al.
Neurosurgery|March 11, 2021
Sport-Related Structural Brain Injury and Return to Play: Systematic Review and Expert InsightScott L Zuckerman, Aaron M Yengo-Kahn, Alan R Tang, et al.
Nature Genetics|August 28, 2012
A low-frequency variant at 8q24.21 is strongly associated with risk of oligodendroglial tumors and astrocytomas with IDH1 or IDH2 mutationRobert B Jenkins, Yuanyuan Xiao, Hugues Sicotte, et al.
The Lancet. Oncology|October 3, 2024
A brave new framework for glioma drug developmentKelly M Hotchkiss, Philipp Karschnia, Karisa C Schreck, et al.
The Lancet. Diabetes & Endocrinology|September 9, 2024
Effect of sodium-glucose co-transporter-2 inhibitors on survival free of organ support in patients hospitalised for COVID-19 (ACTIV-4a): a pragmatic, multicentre, open-label, randomised, controlled, platform trialMikhail N Kosiborod, Sheryl L Windsor, Orly Vardeny, et al.
JAMA Oncology|February 7, 2020
Association of Maximal Extent of Resection of Contrast-Enhanced and Non-Contrast-Enhanced Tumor With Survival Within Molecular Subgroups of Patients With Newly Diagnosed GlioblastomaAnnette M Molinaro, Shawn Hervey-Jumper, Ramin A Morshed, et al.
The New England Journal of Medicine|June 11, 2015
Glioma Groups Based on 1p/19q, IDH, and TERT Promoter Mutations in TumorsJeanette E Eckel-Passow, Daniel H Lachance, Annette M Molinaro, et al.
Acta Neuropathologica|April 19, 2020
Pediatric bithalamic gliomas have a distinct epigenetic signature and frequent EGFR exon 20 insertions resulting in potential sensitivity to targeted kinase inhibitionGourish Mondal, Julieann C Lee, Ajay Ravindranathan, et al.
Neuro-Oncology|July 12, 2023
Novel SOX10 indel mutations drive schwannomas through impaired transactivation of myelination gene programsErik A Williams, Ajay Ravindranathan, Rohit Gupta, et al.
Pageof 166